Evidence map›Paper›PMID 42352898›Full record

ReviewInternational journal of molecular sciences2026

Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions.

Tereza Růžičková, Michal Kaščák, Zuzana Chyra, Viera Sandecká, Jana Kotašková, Sabina Ševčíková

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tereza RůžičkováBabak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0009-0002-5758-7087
Michal KaščákDepartment of Hematooncology, University Hospital Ostrava, 708 00 Ostrava, Czech Republic.
Zuzana ChyraDepartment of Hematooncology, University Hospital Ostrava, 708 00 Ostrava, Czech Republic.
Viera SandeckáDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno, 625 00 Brno, Czech Republic.
Jana KotaškováDepartment of Hematooncology, University Hospital Ostrava, 708 00 Ostrava, Czech Republic.
Sabina ŠevčíkováBabak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0002-7194-6771

Funding

European Union Program EXCELES, ID Project No. LX22NPO5102Masaryk University FM MU MUNI/11/PU/1/2025Masaryk University MUNI/A/1698/2025Ministry of Health NW26-03-00001University Hospital Brno DRO FNBr 65269705University of Ostrava SGS09/LF/2025
6 · The paper itself

Abstract

Waldenström macroglobulinemia is a rare lymphoplasmacytic malignancy characterized by bone marrow infiltration and monoclonal immunoglobulin M production. Despite its indolent clinical course, the disease exhibits considerable biological complexity driven by recurrent genetic alterations, dysregulated signaling pathways, and a supportive bone marrow microenvironment. The identification of

Indexed as

EpigenomicsGenomicsWaldenstrom MacroglobulinemiaAnimalsEpigenesis, GeneticHumansMicroRNAsMutationMyeloid Differentiation Factor 88Receptors, CXCR4Signal TransductionCXCR4 protein, humanMicroRNAsMYD88 protein, humanMyeloid Differentiation Factor 88Receptors, CXCR4CXCR4L252PL265PmicroRNAMYD88signaling pathwaysTP53Waldenström macroglobulinemia

Identifiers

PMID42352898
PMCPMC13299230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.